ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,00%
Bitcoin
60.911,93
0,19%
Brent Oil
82,585
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Avalon Pharmaceuticals (MM) (AVRX)

  7. Avalon Pharmaceuticals (MM) (AVRX) Notícias

AVRX

Avalon (AVRX)

Avalon Pharmaceuticals (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVRX
DataHoraFonteTítuloCódigoCompanhia
13/05/200916:39Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
06/05/200917:48Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
06/05/200917:46Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
28/04/200917:49Business WireAvalon Pharmaceuticals Announces Special Meeting DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/04/200916:00Business WireAvalon Pharmaceuticals Receives Audit Opinion Containing Going Concern StatementNASDAQ:AVRXAvalon Pharmaceuticals (MM)
17/03/200916:00Business WireAvalon Pharmaceuticals Receives Staff Determination Regarding Nasdaq DelistingNASDAQ:AVRXAvalon Pharmaceuticals (MM)
10/03/200917:07Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
11/02/200919:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
10/02/200920:04Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
22/12/200819:23Business WireAvalon Pharmaceuticals Receives Extension of Time to Comply with NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
25/11/200817:18Business WireAvalon Pharmaceuticals Receives NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/11/200819:04Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
05/11/200819:29Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
28/10/200810:26Business WireClinical Data, Inc. to Acquire Avalon PharmaceuticalsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
29/09/200816:16Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/09/200817:16Business WireAvalon Pharmaceuticals Receives Nasdaq Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/08/200812:02Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
14/08/200812:53Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
13/08/200811:00Business WireAvalon Pharmaceuticals Reports Second Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
05/08/200810:00Business WireAvalon Pharmaceuticals Sets Second Quarter 2008 Conference Call DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
24/07/200813:07Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Amended Current report filing (8-K/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
18/07/200815:23Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/06/200809:00Business WireAvalon Pharmaceuticals Nominates Lead Clinical Development Candidate in its Beta-catenin Pathway Inhibitor ProgramNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/05/200817:20Business WireAvalon Pharmaceuticals Reports First Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
30/04/200809:00Business WireAvalon Pharmaceuticals to Release First Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
29/04/200810:54Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
14/04/200812:00Business WireAvalon Pharmaceuticals Identifies Small Molecule Inhibitors of the Aurora/Centrosome Cancer Pathway that Block PLK3 Protein FuncNASDAQ:AVRXAvalon Pharmaceuticals (MM)
31/03/200815:34Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
19/03/200817:15Business WireAvalon Pharmaceuticals Reports Fourth Quarter and Full Year 2007 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
17/03/200816:57Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVRX

Seu Histórico Recente

COIN
SWTHETH
Switcheo
BOV
R1CL34M
Royal Caribbean
OKEX
WAVESBTC
Waves
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados